Mercy Health Saint Mary's, Grand Rapids, MI, USA.
Ferris State University, Big Rapids, MI, USA.
Ann Pharmacother. 2022 Jan;56(1):52-59. doi: 10.1177/10600280211016856. Epub 2021 May 17.
Opioids are a mainstay of therapy for patients in the intensive care unit (ICU) as part of the analgesia-first approach to sedation. Despite knowledge of acute consequences of opioid based analgosedation, less is known about the potential long-term consequences, including the effect of opioid administration in the ICU on subsequent opioid use in opioid-naïve patients.
To evaluate the relationship between ICU opioid administration to opioid-naïve patients and subsequent opioid use following discharge.
A query of the electronic medical record was performed to identify opioid-naïve adult patients admitted directly to an ICU. Patients who received continuous intravenous infusion of fentanyl, hydromorphone, or morphine were screened for inclusion into the analysis.
Of the 342 patients included for analysis, 164 (47.1%) received an opioid at hospital discharge. In total, 17 of the 342 patients (5.0%) became long-term users, noted to be more common in patients who received an opioid prescription at discharge (8.7% vs 1.6%; = 0.006). Neither total ICU morphine milligram equivalent (MME) nor average daily ICU MME administration were found to correlate with daily MME prescription quantity at discharge ( = 0.008 and = 0.03, respectively). Following control for potentially confounding variables, total ICU MME administration remained an insignificant predictor of subsequent receipt of an opioid prescription at discharge and long-term opioid use.
This study failed to find a significant relationship between ICU opioid use in opioid-naïve patients and subsequent opioid use. These findings highlight the need to focus on transitions points between the ICU and discharge as potential opportunities to reduce inappropriate opioid continuation.
在重症监护病房(ICU)中,阿片类药物是治疗患者的主要方法,是镇静治疗中首先考虑镇痛的一部分。尽管人们了解阿片类药物基础镇痛镇静的急性后果,但对潜在的长期后果知之甚少,包括 ICU 中阿片类药物的使用对随后接受阿片类药物治疗的阿片类药物初治患者的影响。
评估 ICU 给予阿片类药物初治患者与出院后随后使用阿片类药物之间的关系。
对电子病历进行查询,以确定直接入住 ICU 的阿片类药物初治成年患者。对接受芬太尼、氢吗啡酮或吗啡持续静脉输注的患者进行筛选,纳入分析。
在纳入分析的 342 例患者中,有 164 例(47.1%)在出院时接受了阿片类药物。在总共 342 例患者中,有 17 例(5.0%)成为长期使用者,发现在出院时接受阿片类药物处方的患者中更为常见(8.7%比 1.6%;=0.006)。ICU 吗啡毫克当量(MME)总量和 ICU 平均日 MME 给药均与出院时每日 MME 处方量无关(=0.008 和=0.03)。在控制了潜在的混杂变量后,ICU 总 MME 给药仍不能预测出院时接受阿片类药物处方和长期使用阿片类药物。
本研究未发现 ICU 中阿片类药物初治患者的使用与随后使用阿片类药物之间存在显著关系。这些发现强调需要关注 ICU 与出院之间的过渡点,作为减少不适当阿片类药物继续使用的潜在机会。